Nutritional Status Is Superior to the ECOG Performance Status in Predicting the Dose-Intensity of the GEMOX Chemotherapy Regimen in Patients with Advanced Cancer

REFERENCES

• Pressoir , M , Desne , S , Berchery , D , Rossignol , G Poiree , B . 2010 . Prevalence, risk factors and clinical implications of malnutrition in French Comprehensive Cancer Centres . Br J Cancer , 102 : 966 – 971 .
   PubMed Web of Science ®Google Scholar
• Alexandre , J , Gross-Goupil , M , Falissard , B , Nguyen , M L Gornet , J M . 2003 . Evaluation of the nutritional and inflammatory status in cancer patients for the risk assessment of severe haematological toxicity following chemotherapy . Ann Oncol , 14 : 36 – 41 .
   PubMed Web of Science ®Google Scholar
• Conill , C , Verger , E and Salamero , M . 1990 . Performance status assessment in cancer patients . Cancer , 65 : 1864 – 1866 .
   PubMed Web of Science ®Google Scholar
• Goldwasser , F , Gross-Goupil , M , Tigaud , J M , Di Palma , M Marceau-Suissa , J . 2000 . Dose escalation of CPT-11 in combination with oxaliplatin using an every two weeks schedule: a phase I study in advanced gastrointestinal cancer patients . Ann Oncol , 11 : 1463 – 1470 .
   PubMed Web of Science ®Google Scholar
• Huang , P I , Chao , Y , Li , C P , Lee , R C Chi , K H . 2009 . Efficacy and factors affecting outcome of gemcitabine concurrent chemoradiotherapy in patients with locally advanced pancreatic cancer . Int J Radiat Oncol Biol Phys , 73 ( 1 ) : 159 – 165 .
   PubMed Web of Science ®Google Scholar
• Maltoni , M , Pirovano , M , Scarpi , E , Marinari , M Indelli , M . 1995 . Prediction of survival of patients terminally ill with cancer. Results of an Italian prospective multicentric study . Cancer , 75 : 2613 – 2622 .
   PubMed Web of Science ®Google Scholar
• Ray-Coquard , I , Borg , C , Bachelot , T , Fayette , J Zufferey , L . 2006 . Prognostic factors for febrile neutropenia . Bull Cancer , 93 : 501 – 506 .
   PubMed Web of Science ®Google Scholar
• Alexandre , J , Rey , E , Girre , V , Grabar , S Tran , A . 2007 . Relationship between cytochrome 3A activity, inflammatory status and the risk of docetaxel-induced febrile neutropenia: a prospective study . Ann Oncol , 18 : 168 – 172 .
   PubMed Web of Science ®Google Scholar
• Wildiers , H and Reiser , M . 2010 . Relative dose intensity of chemotherapy and its impact on outcomes in patients with early breast cancer or aggressive lymphoma . Crit Rev Oncol Hematol , 120 : 1253 – 1262 .
   Google Scholar
• Grimison , P S , Stockler , M R , Thomson , D B , Olver , I N Harvey , V J . 2010 . Comparison of two standard chemotherapy regimens for good-prognosis germ cell tumors: updated analysis of a randomized trial . J Natl Cancer Inst , 77 : 221 – 240 .
   Google Scholar
• Hasenberg , T , Essenbreis , M , Herold , A , Post , S and Shang , E . 2009 . Early supplementation of parenteral nutrition is capable of improving quality of life, chemotherapy-related toxicity and body composition in patients with advanced colorectal carcinoma undergoing palliative treatment Results from a prospective, randomized clinical trial . Colorectal Dis , 12 : e190 – e199 .
   Web of Science ®Google Scholar
• Salas , S , Baumstarck-Barrau , K , Alfonsi , M , Digue , L Bagarry , D . 2009 . Impact of the prophylactic gastrostomy for unresectable squamous cell head and neck carcinomas treated with radio-chemotherapy on quality of life: Prospective randomized trial . Radiother Oncol , 93 : 503 – 509 .
   PubMed Web of Science ®Google Scholar
• Barret , M , Malka , D , Aparicio , T , Dalban , C Locher , C . 2011 . Nutritional status affects treatment tolerability and survival in metastatic colorectal cancer patients: results of an AGEO prospective multicenter study . Oncology , 81 : 395 – 402 .
   PubMed Web of Science ®Google Scholar
• Sanchez-Lara , K , Turcott , J G , Juarez , E , Guevara , P Nunez-Valencia , C . 2012 . Association of nutrition parameters including bioelectrical impedance and systemic inflammatory response with quality of life and prognosis in patients with advanced non-small-cell lung cancer: a prospective study . Nutr Cancer , 64 : 526 – 534 .
   PubMed Web of Science ®Google Scholar
• Qiu , C , Yang , N , Tian , G and Liu , H . 2011 . Weight loss during radiotherapy for nasopharyngeal carcinoma: a prospective study from northern China . Nutr Cancer , 63 : 873 – 879 .
   PubMed Web of Science ®Google Scholar
• Mateus , C , Lemarie , E , Goldwasser , F , Michalet , M Beauvilain De Montreuil , C . 2006 . Prevalence of malnutrition in non-selected cancer patients: a one day survey . Ann Oncol , 17 ( Suppl 9 ) : ix298
   Google Scholar
• Slaviero , K A , Read , J A , Clarke , S J and Rivory , L P . 2003 . Baseline nutritional assessment in advanced cancer patients receiving palliative chemotherapy . Nutr Cancer , 46 : 148 – 157 .
   PubMed Web of Science ®Google Scholar
• Tong , H , Isenring , E and Yates , P . 2009 . The prevalence of nutrition impact symptoms and their relationship to quality of life and clinical outcomes in medical oncology patients . Support Care Cancer , 17 : 83 – 90 .
   PubMed Web of Science ®Google Scholar
• Capuano , G , Gentile , P C , Bianciardi , F , Tosti , M and Palladino , A . 2010 . Prevalence and influence of malnutrition on quality of life and performance status in patients with locally advanced head and neck cancer before treatment . Support Care Cancer , 18 : 433 – 437 .
   PubMed Web of Science ®Google Scholar
• Louvet , C , Labianca , R , Hammel , P , Lledo , G Zampino , M G . 2005 . Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer: results of a GERCOR and GISCAD phase III trial . J Clin Oncol , 23 : 3509 – 3516 .
   PubMed Web of Science ®Google Scholar
• Andre , T , Reyes-Vidal , J M , Fartoux , L , Ross , P Leslie , M . 2008 . Gemcitabine and oxaliplatin in advanced biliary tract carcinoma: a phase II study . Br J Cancer , 99 : 862 – 867 .
   PubMed Web of Science ®Google Scholar
• Weissman , C H , Reynolds , C H , Neubauer , M A , Pritchard , S and Kobina , S . 2011 . A phase III randomized trial of gemcitabine-oxaliplatin versus carboplatin-paclitaxel as first-line therapy in patients with advanced non-small cell lung cancer . J Thorac Oncol , 6 : 358 – 364 .
   PubMed Web of Science ®Google Scholar
• Strother , D , Ashley , D , Kellie , S J , Patel , A Jones-Wallace , D . 2001 . Feasibility of four consecutive high-dose chemotherapy cycles with stem-cell rescue for patients with newly diagnosed medulloblastoma or supratentorial primitive neuroectodermal tumor after craniospinal radiotherapy: results of a collaborative study . J Clin Oncol , 19 : 2696 – 2704 .
   PubMed Web of Science ®Google Scholar
• Brusamolino , E , Rusconi , C , Montalbetti , L , Gargantini , L Uziel , L . 2006 . Dose-dense R-CHOP-14 supported by pegfilgrastim in patients with diffuse large B-cell lymphoma: a phase II study of feasibility and toxicity . Haematologica , 91 : 496 – 502 .
   PubMed Web of Science ®Google Scholar
• Perez-Soler , R , Chachoua , A , Hammond , L A , Rowinsky , E K Huberman , M . 2004 . Determinants of tumor response and survival with erlotinib in patients with non–small-cell lung cancer . J Clin Oncol , 22 : 3238 – 3247 .
   PubMed Web of Science ®Google Scholar
• Andreyev , H J , Norman , A R , Oates , J and Cunningham , D . 1998 . Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies? . Eur J Cancer , 34 : 503 – 509 .
   PubMed Web of Science ®Google Scholar
• Sorensen , J B , Klee , M , Palshof , T and Hansen , H H . 1993 . Performance status assessment in cancer patients. An inter-observer variability study . Br J Cancer , 67 : 773 – 775 .
   PubMed Web of Science ®Google Scholar
• Crumley , A B , Stuart , R C , McKernan , M , McDonald , A C and McMillan , D C . 2008 . Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG-ps) in patients receiving palliative chemotherapy for gastroesophageal cancer . J Gastroenterol Hepatol , 23 ( 8, Pt 2 ) : e325 – e329 .
   PubMed Web of Science ®Google Scholar
• Forrest , L M , McMillan , D C , McArdle , C S , Angerson , W J and Dunlop , D J . 2004 . Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG) in patients receiving platinum-based chemotherapy for inoperable non-small-cell lung cancer . Br J Cancer , 90 : 1704 – 1706 .
   PubMed Web of Science ®Google Scholar